CA
ZBIO icon

CoreCap Advisors’s Zenas BioPharma ZBIO Stock Holding History

CoreCap Advisors’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$324 Hold
12
– – ﹤0.01% 2880
2026
Q2 		$305 Buy
+12
New +$239 ﹤0.01% 2940

Other funds holding ZBIO

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors's ZBIO Position: Q3 2026 in Review

CoreCap Advisors held its Zenas BioPharma (ZBIO) position steady in Q3 2026 at 12 shares worth $324. The position accounts for ﹤0.01% of the portfolio, ranked #2880.

CoreCap Advisors first reported a position in ZBIO in Q2 2026 and has held it in 2 quarters since. 3 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

  • CoreCap Advisors held 12 shares of Zenas BioPharma worth $324 as of Q3 2026.
  • CoreCap Advisors left its Zenas BioPharma share count unchanged in Q3 2026.
  • Zenas BioPharma made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2880 holding.
  • CoreCap Advisors first reported a position in Zenas BioPharma in Q2 2026 and has held it in 2 quarters since.
  • 3 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.